Diaphorina citri psyllid: psy16378

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------58
MTQLDNKPLDNGNKLRRVIQKFLNTSAINNLPPTTTATTTVFTHFVASSVDTQTTWGSNYTTVLFNVTTPSPEFFSNLTTMVTPTSPYFLDKEPRFTTTQVIIIATFAAFLSIVTVLGNILVMVSFKIDKTLQTISNYFLIVTVLGNILVMVSFKIDKTLQTISNYFLFSLAVADFAIGAISMPLFTVYTILGYWPLGPMVCDTWLALDYLASNASVLNLLIISFDRYFSVTRPLTYRAKRTTKRAACMIVTAWGVSMILWPPWIFAWPYIEGERRVPYYECYIQFIETNHYITFLTAIAAFYIPVSVMIFLYLRIYKETEKRKKEFSNLQAAGKKDSSKRSTSRINRKPRPFSRKFIQEWCIAWWHSGREEDPDCDLDDTPSDIGGYATPVSVETPVTSCVSRCTSLNVIKDSTKQQTPPTRIHHVYTILIRLPLETDGSGDQPSIKMIPDENLPRLGKHPDFPAQNAAALNRRPSHISDIRIPLNAKMMNKNAKLLGKQVALGKKKKKSQEKKAERKAAKTLILVLLKPITTCSECIPNGLWDFFYYLCYINSTINPVCYALCNDAFRATYIRILT
ccccccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHcEEEEEEEEEccccccccHHHHHHHHHHHHHHHHHcccHHHHHHHccCCccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccEEEEEccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccHHHcccHHHHHHHHHHHHHHHHHHHHEEEcccccccccccHHHHHHHHHHHHHcccccHHHHHHccHHHHHHHHHHHc
******KPLDNGNKLRRVIQKFLNTS****L***TTATTTVFTHFVASSVDTQTTWGSNYTTVLFNVTTPSPEFFSNLTTMVTPTSPYFLDKEPRFTTTQVIIIATFAAFLSIVTVLGNILVMVSFKIDKTLQTISNYFLIVTVLGNILVMVSFKIDKTLQTISNYFLFSLAVADFAIGAISMPLFTVYTILGYWPLGPMVCDTWLALDYLASNASVLNLLIISFDRYFSVTRPLTYRAKRTTKRAACMIVTAWGVSMILWPPWIFAWPYIEGERRVPYYECYIQFIETNHYITFLTAIAAFYIPVSVMIFLYLRIYKET*************************************************************************************************************ILIRLPLETDG************************************************************************EKKAERKAAKTLILVLLKPITTCSECIPNGLWDFFYYLCYINSTINPVCYALCNDAFRATYIRILT
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MTQLDNKPLDNGNKLRRVIQKFLNTSAINNLPPTTTATTTVFTHFVASSVDTQTTWGSNYTTVLFNVTTPSPEFFSNLTTMVTPTSPYFLDKEPRFTTTQVIIIATFAAFLSIVTVLGNILVMVSFKIDKTLQTISNYFLIVTVLGNILVMVSFKIDKTLQTISNYFLFSLAVADFAIGAISMPLFTVYTILGYWPLGPMVCDTWLALDYLASNASVLNLLIISFDRYFSVTRPLTYRAKRTTKRAACMIVTAWGVSMILWPPWIFAWPYIEGERRVPYYECYIQFIETNHYITFLTAIAAFYIPVSVMIFLYLRIYKETEKRKKEFSNLQAAGKKDSSKRSTSRINRKPRPFSRKFIQEWCIAWWHSGREEDPDCDLDDTPSDIGGYATPVSVETPVTSCVSRCTSLNVIKDSTKQQTPPTRIHHVYTILIRLPLETDGSGDQPSIKMIPDENLPRLGKHPDFPAQNAAALNRRPSHISDIRIPLNAKMMNKNAKLLGKQVALGKKKKKSQEKKAERKAAKTLILVLLKPITTCSECIPNGLWDFFYYLCYINSTINPVCYALCNDAFRATYIRILT

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Muscarinic acetylcholine receptor gar-3 The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover.confidentQ9U7D5
Muscarinic acetylcholine receptor M3 The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover.confidentP41984
Muscarinic acetylcholine receptor M3 The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover.confidentP49578

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0043679 [CC]axon terminusprobableGO:0044306, GO:0044463, GO:0044464, GO:0005623, GO:0030424, GO:0005575, GO:0097458, GO:0043005, GO:0033267, GO:0042995
GO:0043025 [CC]neuronal cell bodyprobableGO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0008144 [MF]drug bindingprobableGO:0003674, GO:0005488
GO:0032279 [CC]asymmetric synapseprobableGO:0005575, GO:0045202
GO:0071883 [BP]activation of MAPK activity by adrenergic receptor signaling pathwayprobableGO:0000187, GO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0048584, GO:0048583, GO:0032147, GO:0023056, GO:0043406, GO:0043405, GO:0023052, GO:0007165, GO:0007166, GO:0023051, GO:0071902, GO:0010647, GO:0071900, GO:0010627, GO:0050789, GO:0044699, GO:0043408, GO:0051716, GO:0010646, GO:0051347, GO:0010604, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0043085, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0051174, GO:0010740, GO:0050790, GO:0045937, GO:0060255, GO:0031323, GO:0045859, GO:0080090, GO:0050794, GO:0043410, GO:0071875, GO:0032268, GO:0044763, GO:0007154, GO:0065009, GO:0042325, GO:0044700, GO:0042327, GO:0001932, GO:0007186, GO:0050896, GO:0031401, GO:0051338, GO:0008150, GO:0009987, GO:0045860, GO:0001934, GO:0048522
GO:0004993 [MF]serotonin receptor activityprobableGO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0008227
GO:0014070 [BP]response to organic cyclic compoundprobableGO:0042221, GO:0050896, GO:0008150, GO:0010033
GO:0007274 [BP]neuromuscular synaptic transmissionprobableGO:0044700, GO:0019226, GO:0032501, GO:0044707, GO:0035637, GO:0050877, GO:0009987, GO:0008150, GO:0044763, GO:0023052, GO:0007268, GO:0007267, GO:0007154, GO:0044699, GO:0003008
GO:0090316 [BP]positive regulation of intracellular protein transportprobableGO:0033157, GO:0070201, GO:0032879, GO:0032388, GO:0060341, GO:0051050, GO:0051049, GO:0032386, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0051222, GO:0051223, GO:0050789, GO:0032880
GO:1901700 [BP]response to oxygen-containing compoundprobableGO:0042221, GO:0050896, GO:0008150
GO:0051378 [MF]serotonin bindingprobableGO:0043169, GO:0097159, GO:0043167, GO:0003674, GO:0005488, GO:0043176, GO:1901363
GO:0032148 [BP]activation of protein kinase B activityprobableGO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0031323, GO:0032147, GO:0045860, GO:0050789, GO:0043085, GO:0080090, GO:0051347, GO:0010604, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0065009, GO:0050790, GO:0045937, GO:0060255, GO:0045859, GO:0050794, GO:0051174, GO:0008150, GO:0042325, GO:0042327, GO:0032268, GO:0031401, GO:0051338, GO:0001932, GO:0001934, GO:0048522
GO:0045664 [BP]regulation of neuron differentiationprobableGO:0030154, GO:0007275, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0050789, GO:0008150, GO:0065007, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0044763, GO:0051239, GO:0022008, GO:0048699, GO:0007399, GO:0044707, GO:0048856, GO:0051960, GO:2000026, GO:0048731
GO:0051179 [BP]localizationprobableGO:0008150
GO:0010648 [BP]negative regulation of cell communicationprobableGO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0044260 [BP]cellular macromolecule metabolic processprobableGO:0009987, GO:0044237, GO:0043170, GO:0071704, GO:0008150, GO:0008152
GO:0007189 [BP]adenylate cyclase-activating G-protein coupled receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0050789, GO:0007188, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0007187, GO:0044699
GO:0046983 [MF]protein dimerization activityprobableGO:0003674, GO:0005488, GO:0005515
GO:0044057 [BP]regulation of system processprobableGO:0008150, GO:0065007, GO:0050789, GO:0051239
GO:0043270 [BP]positive regulation of ion transportprobableGO:0051050, GO:0051049, GO:0065007, GO:0048518, GO:0008150, GO:0032879, GO:0050789, GO:0043269
GO:0051379 [MF]epinephrine bindingprobableGO:1901338, GO:0003674, GO:0005488, GO:0097159
GO:0051924 [BP]regulation of calcium ion transportprobableGO:0051049, GO:0010959, GO:0065007, GO:0008150, GO:0032879, GO:0050789, GO:0043269
GO:0014069 [CC]postsynaptic densityprobableGO:0030425, GO:0043229, GO:0043228, GO:0044430, GO:0044327, GO:0043226, GO:0005856, GO:0044446, GO:0044309, GO:0097458, GO:0044456, GO:0043005, GO:0042995, GO:0043197, GO:0043232, GO:0044463, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424, GO:0044422, GO:0045202
GO:0048585 [BP]negative regulation of response to stimulusprobableGO:0008150, GO:0048519, GO:0065007, GO:0048583, GO:0050789
GO:0007210 [BP]serotonin receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0050789, GO:0044699
GO:0035625 [BP]epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathwayprobableGO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0010647, GO:0048584, GO:0048583, GO:0042058, GO:0023056, GO:0031399, GO:0023052, GO:0007165, GO:0007166, GO:0023051, GO:1901186, GO:1901184, GO:0010646, GO:0050789, GO:0044699, GO:0080090, GO:0051716, GO:0051347, GO:0045937, GO:0048522, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0045742, GO:0043085, GO:0044093, GO:0061097, GO:0061098, GO:0065007, GO:0065009, GO:0010469, GO:0048518, GO:2000273, GO:0045859, GO:0035624, GO:0060255, GO:0031323, GO:0045741, GO:0050794, GO:0051174, GO:0007176, GO:0032268, GO:0044763, GO:0007154, GO:0010604, GO:0042325, GO:0044700, GO:0042327, GO:0001932, GO:0050790, GO:0050731, GO:0007186, GO:0050896, GO:0031401, GO:0051338, GO:0031325, GO:0050730, GO:0008150, GO:0009987, GO:0045860, GO:0001934, GO:0032270
GO:0007194 [BP]negative regulation of adenylate cyclase activityprobableGO:0010563, GO:0031280, GO:0080090, GO:0019222, GO:0031327, GO:0051350, GO:0031324, GO:0031323, GO:0009892, GO:1900371, GO:0045980, GO:0043086, GO:0019220, GO:0009890, GO:0030818, GO:0045761, GO:0030814, GO:0030815, GO:0050789, GO:0065007, GO:0044092, GO:0048519, GO:0065009, GO:0045934, GO:0045936, GO:0019219, GO:0050790, GO:0009889, GO:0050794, GO:0031326, GO:1900542, GO:0008150, GO:0051171, GO:0051172, GO:0030799, GO:0031279, GO:0051174, GO:1900543, GO:0030802, GO:0030809, GO:0030808, GO:1900372, GO:0030800, GO:0030803, GO:0051339, GO:0030817, GO:0006140, GO:0048523
GO:0007197 [BP]adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0007213, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0050789, GO:0007188, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007193, GO:0007186, GO:0007187, GO:0044699
GO:0005737 [CC]cytoplasmprobableGO:0044424, GO:0005575, GO:0044464, GO:0005623, GO:0005622
GO:0005634 [CC]nucleusprobableGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0051241 [BP]negative regulation of multicellular organismal processprobableGO:0008150, GO:0048519, GO:0065007, GO:0050789, GO:0051239
GO:0007200 [BP]phospholipase C-activating G-protein coupled receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0050789, GO:0044699
GO:0005085 [MF]guanyl-nucleotide exchange factor activityprobableGO:0030695, GO:0030234, GO:0060589, GO:0003674
GO:0004938 [MF]alpha2-adrenergic receptor activityprobableGO:0004930, GO:0004936, GO:0004935, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0038023, GO:0008227
GO:0065008 [BP]regulation of biological qualityprobableGO:0008150, GO:0065007
GO:0009719 [BP]response to endogenous stimulusprobableGO:0050896, GO:0008150
GO:0042383 [CC]sarcolemmaprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886
GO:0016907 [MF]G-protein coupled acetylcholine receptor activityprobableGO:0004930, GO:0030594, GO:0038023, GO:0015464, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0008227
GO:0023057 [BP]negative regulation of signalingprobableGO:0008150, GO:0048519, GO:0065007, GO:0050789, GO:0023051
GO:0044238 [BP]primary metabolic processprobableGO:0008150, GO:0008152
GO:0005887 [CC]integral to plasma membraneprobableGO:0031226, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459, GO:0031224

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3UON, chain A
Confidence level:very confident
Coverage over the Query: 98-124,153-333
View the alignment between query and template
View the model in PyMOL
Template: 3RZE, chain A
Confidence level:very confident
Coverage over the Query: 130-331
View the alignment between query and template
View the model in PyMOL
Template: 2VT4, chain A
Confidence level:confident
Coverage over the Query: 128-326
View the alignment between query and template
View the model in PyMOL
Template: 2KOE, chain A
Confidence level:probable
Coverage over the Query: 543-578
View the alignment between query and template
View the model in PyMOL